Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros

Bases de dados
País/Região como assunto
Tipo de documento
Assunto da revista
Intervalo de ano de publicação
2.
Int J Biol Macromol ; 144: 362-372, 2020 Feb 01.
Artigo em Inglês | MEDLINE | ID: mdl-31843607

RESUMO

In present study, pure and amino-carbamate moiety grafted calcium alginate hydrogel beads (CA, PSC-CA) were prepared for their biosorption performance in the recovery of silver ions. The produced sorbents were characterized using FTIR, SEM, EDX and TGA. FTIR and SEM-EDX confirmed the successful modification and loading of silver ions onto hydrogel beads. When compared with CA, PSC-CA showed enhanced sorption but comparable kinetics. Equilibrium sorption studies showed that pH, sorbent dose, contact time and adsorbate concentration influenced the sorption capacity. The uptake kinetic data was well demonstrated by pseudo second order rate equation (PSORE). Elovich equation and the resistance to intra-particle diffusion model (RID) suggested that there were two phases of sorption, first one was rapid followed by relatively slow uptake step. Equilibrium isothermal sorption data was well fitted by Langmuir and Sips models. The separation factor RL was found as 0 < RL < 1 which indicated favourable sorption. The maximum monolayer sorption capacity was computed as 210 mg/g at 298 K. Thermodynamic studies revealed the sorption process to be spontaneous and exothermic. PSC-CA hydrogel beads were found as cost-effective and efficient sorbent for economically-competitive recovery of Ag(I).


Assuntos
Alginatos/química , Carbamatos/química , Hidrogéis/química , Prata/química , Íons , Cinética , Termodinâmica , Água
3.
Transplantation ; 100(6): 1284-93, 2016 06.
Artigo em Inglês | MEDLINE | ID: mdl-26854790

RESUMO

BACKGROUND: Long-term follow-up and management of donors was undertaken in a specialist kidney transplant unit in Pakistan to identify risk and prevent adverse outcomes in living related kidney donors. METHODS: In an observation cohort study between 1985 and 2012, 3748 donors were offered free medical follow-up and treatment 6 to 12 months after donation and annually thereafter. Each visit included history, physical examination, blood tests for renal, lipid, glucose profiles, and 24-hour urine for proteinuria and creatinine clearance. Preventive intervention was undertaken for new onset clinical conditions. Donor outcomes were compared with 90 nondonor healthy siblings matched for age, sex, and body mass index. RESULTS: Of the 3748 donors, 2696 (72%) were in regular yearly follow-up for up to 27 years (median, 5.6; interquartile range, 7.9). Eleven (0.4%) died 4 to 22 years after donation with all-cause mortality of 4.0/10 000 person years. Six (0.2%) developed end-stage renal disease 5 to 17 years after donation, (2.7/10 000 person years). Proteinuria greater than 1000 mg/24 hours developed in 28 patients (1%), hypertension in 371 patients (13.7%), and diabetes in 95 patients (3.6%). Therapeutic intervention-controlled protein was less than 1000 mg/24 hours, blood pressure was below 140/90 mm Hg, and glycemic control in 85% up to 15 years after onset. Creatinine clearance fell from 109.8 ± 22.3 mL/min per 1.73 m predonation to 78 ± 17 at 1 year, 84 ± 19 at 5 years, and 70 ± 20 at 25 years. Comparison of 90 nondonor sibling and donor pairs showed significantly higher fasting glucose and hypertension in nondonors. CONCLUSIONS: Long-term follow-up of donors has demonstrated end-stage renal disease in 0.6% at 25 years. Regular follow-up identified new onset of disease and allowed interventions that may have prevented adverse outcomes.


Assuntos
Falência Renal Crônica/cirurgia , Transplante de Rim/métodos , Doadores Vivos , Segurança do Paciente , Adolescente , Adulto , Idoso , Glicemia/análise , Pressão Sanguínea , Índice de Massa Corporal , Estudos de Coortes , Creatinina/urina , Complicações do Diabetes/cirurgia , Feminino , Seguimentos , Humanos , Hiperlipidemias/complicações , Hipertensão/complicações , Rim/fisiopatologia , Falência Renal Crônica/economia , Falência Renal Crônica/etiologia , Transplante de Rim/economia , Masculino , Pessoa de Meia-Idade , Nefrectomia , Obesidade/complicações , Paquistão , Proteinúria/urina , Fatores de Risco , Irmãos , Fatores de Tempo , Coleta de Tecidos e Órgãos , Resultado do Tratamento , Adulto Jovem
4.
Curr Opin Organ Transplant ; 14(2): 124-8, 2009 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-19469028

RESUMO

PURPOSE OF REVIEW: Paid living unrelated kidney donor transplantation has flourished in Pakistan and Iran. This review discusses the dynamics and consequences of organ trade in Pakistan and of a regulated paid donor model in Iran on transplant activities in these countries. RECENT FINDINGS: In 2007, over 2500 renal transplants were performed in Pakistan, where more than 70% were from socioeconomic disadvantaged kidney vendors. More than half of recipients were foreigners who paid US$20,000-30,000. Recipients of vendor kidneys had poor outcome and high infectious complications. Regulated paid donor kidney transplant in Iran number around 1500 per year and constitute 70% of the total transplants. Graft survival rates are similar to those for living related donors. The donors are paid US$1200 and additional monies are negotiated between the recipient-donor pair. This model claims to have abolished waiting lists, although many poor patients wait for deceased donors. In both countries, recipients are relatively rich and vendors are the poor of the society who sell kidneys for quick money or to repay debts. SUMMARY: Paid donation, regulated or commercial, leads to coercion and exploitation of the poor and benefits the rich. This situation has forestalled deceased donor program and hence other solid-organ transplants. The way forward is to promote deceased donors by making transplant available to all who need it.


Assuntos
Comércio/economia , Compensação e Reparação/legislação & jurisprudência , Regulamentação Governamental , Política de Saúde , Transplante de Rim/economia , Doadores Vivos/legislação & jurisprudência , Motivação , Obtenção de Tecidos e Órgãos/economia , Comércio/legislação & jurisprudência , Acessibilidade aos Serviços de Saúde/economia , Acessibilidade aos Serviços de Saúde/legislação & jurisprudência , Humanos , Irã (Geográfico) , Transplante de Rim/legislação & jurisprudência , Doadores Vivos/provisão & distribuição , Paquistão , Direitos do Paciente , Desenvolvimento de Programas , Avaliação de Programas e Projetos de Saúde , Fatores Socioeconômicos , Obtenção de Tecidos e Órgãos/legislação & jurisprudência , Viagem
5.
Transpl Int ; 22(6): 615-21, 2009 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-19207189

RESUMO

Donor shortage and absence of transplant law lead to unrelated commercial transplants in Pakistan. We report the socio-economic and outcome parameters of 126 local recipients of unrelated kidney vendor transplants presenting to our institute between 1997 and 2007. Their outcome was compared with 180 recipients of living-related donor transplants matched for age, gender and transplant duration as controls. Age of commercial recipients was 35.63 +/- 11.57 years with an M:F ratio of 2.4:1. Majority (92%) were transplanted in northern Pakistan paying US$7271 +/- 2198. All were educated with 50% being graduates or above and rich earning a monthly salary of US$517 +/- 518 with 44% earning >US$500. Comparison of commercial recipients with controls showed high comorbidities 35 (28%) vs. 14 (8%) (P = 0.0001) with diabetes, hepatitis-C and cardiovascular diseases. Donor age was 29.97 +/- 6.16 vs. 32.63 +/- 9.3 years (P = 0.035). Biologic agents induction in 101 (80%) vs. 14 (8%) (P = 0.0001), acute rejections in 42 (33%) vs. 31 (17%) (P = 0.005), 1-year creatinine 1.84 +/- 1.28 vs. 1.27 +/- 0.4 mg/dl (P = 0.0001), surgical complications 28 (22%) vs. 14 (8%) (P = 0.001), tuberculosis 14 (11%) vs. 6 (6%) (P = 0.007), acute hepatitis 20 (16%) vs. 3 (2%) (P = 0.0001), cytomegalovirus 33 (26%) vs. 21 (11%) (P = 0.001) and recurrent urinary tract infection 35 (28%) vs. 30 (16%) (P = 0.034). Overall 1- and 5-year graft survival was 86% and 45% vs. 94% and 80%, respectively (P = 0.00001). Total deaths were 34 (27%) vs. 12 (6.0%) (P = 0.001). In conclusion, recipients of the vended kidneys are poor candidates, educated, rich and often self-selecting. Their outcome is poor, which will leave them poorer still and back to dialysis if not death.


Assuntos
Falência Renal Crônica/cirurgia , Transplante de Rim/economia , Doadores Vivos , Adolescente , Adulto , Comorbidade , Feminino , Sobrevivência de Enxerto , Humanos , Falência Renal Crônica/economia , Transplante de Rim/imunologia , Masculino , Pessoa de Meia-Idade , Paquistão , Fatores Socioeconômicos , Obtenção de Tecidos e Órgãos/economia , Resultado do Tratamento
6.
Kidney Int Suppl ; (83): S96-100, 2003 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-12864884

RESUMO

Healthcare in developing countries less funded than developed nations (0.8 to 4% vs. 10 to 15%, respectively), and must contend against approximately 1/3 of the population living below the poverty line ($1US/day), poor literacy (58% males/29% females), and less access to potable water and basic sanitation. Cultural and societal constraints combine with these economic obstacles to translate into poor transplantation activity. Donor shortage is a universal problem. Paid donation comprises 50% of all transplants in Pakistan. Post-transplant infections are a major problem in developing countries, with 15% developing tuberculosis, 30% cytomegalovirus, and nearly 50% bacterial infections. The solutions to these problems may seem simplistic: alleviate poverty, educate the general population, and expand the transplant programs in public sector hospitals where commerce is less likely to play a major role. The SIUT model of funding in a community-government partnership has increased the number of transplantations and patient and organ survival substantially. Over the last 15 years, it has operated by complete financial transparency, public audit and accountability. The scheme has proven effective and currently 110 transplants/year are performed, with free after care and immunosuppressive drugs. Confidence has been built in the community, with strong donations of money, equipment and medicines. We believe this model could be sustained in other developing nations.


Assuntos
Países em Desenvolvimento , Falência Renal Crônica/cirurgia , Transplante de Rim/estatística & dados numéricos , Humanos , Falência Renal Crônica/economia , Transplante de Rim/economia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA